Regentis Biomaterials Ltd.

About Regentis Biomaterials Ltd.

Regentis Biomaterials is a tissue repair company dedicated to developing and commercializing an innovative hydrogel platform for the repair of damaged tissue. Their vision is to create effective therapies that shorten recovery times and improve patients' quality of life, with a current focus on orthopedic treatments using resorbable hydrogel implants.

Products & Services

Gelrin Technology:A resorbable hydrogel implant platform for regenerating damaged or diseased tissue, particularly for orthopedic treatments. The manufacturing process meets strict international safety, quality, and biocompatibility standards, including GMP and ISO 13485.

GelrinC

Gelrin

Specialties

Tissue repair Hydrogel technology Orthopedic treatments regenerative medicine orthopedic treatments degradable hydrogel implants cartilage repair tissue engineering

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 6500000 MR: - FA: $6.5 million FAN: 6500000	D: 2026-06-17 FD: 2026-06-17	1 investors
2	RT: IPO T: - FT: IPO	A: 10000000 MR: - FA: $10,000,000 FAN: 10000000	D: 2025-12-05 FD: 2025-12-05	1 investors
3	RT: Initial Public Offering T: - FT: Initial Public Offering	A: 10000000 MR: - FA: $10,000,000 FAN: 10000000	D: 2025-12-03 FD: 2025-12-03	1 investors

Private Placement Latest

2026-06-17

$6.5M

1 investor (Pro only)

IPO 2025-12-05

$10.0M

Initial Public Offering 2025-12-03

$10.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News